This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cardior Pharmaceuticals Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Claudia Ulbrich - Innovator in Cardiac Treatment
Introduction
Claudia Ulbrich is a notable inventor based in Hannover, Germany. She is currently associated with Novo Nordisk A/S, where she contributes to advancements in medical science. Although she has not yet been granted any patents, her work is focused on significant innovations in the treatment of heart failure.
Latest Patent Applications
Claudia Ulbrich's latest patent application is titled "Treatment of Heart Failure in Human Subjects." This invention refers to an oligonucleotide that serves as an effective inhibitor of microRNA miR-132. It highlights its potential use in medicine, particularly in the prevention or treatment of cardiac and/or fibrotic disorders in human subjects.
Conclusion
Claudia Ulbrich's contributions to the field of cardiac treatment demonstrate her commitment to medical innovation. Her ongoing research and patent applications may pave the way for future breakthroughs in healthcare.